IMAGE: A Comparison of AlloMap Molecular Testing and Traditional Biopsy-based Surveillance for Heart Transplant Rejection

Trial ID or NCT#

NCT00351559

Status

not recruiting iconNOT RECRUITING

Purpose

This study is designed to evaluate the safety and efficacy of a leukocyte gene expression profiling method in the monitoring of asymptomatic heart transplant patients for acute rejection.

Official Title

Invasive Monitoring Attenuation Through Gene Expression (IMAGE) Trial

Eligibility Criteria

Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: No
Show Less

Investigator(s)

Sharon Markham Geaghan
Hannah Valantine
Hannah Valantine
Cardiologist
Professor of Medicine (Cardiovascular)

View on ClinicalTrials.gov